Molecular Testing in Metastatic Gastric/GEJ Cancer
3 Visningar
administrator
06/30/23
David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.
Visa mer
Facebook-kommentarer
Inga kommentarer hittades